Presentation of PRISM study posters at the PNS virtual congress on 27 June 2020
For the first time, the results of the PRISM study, a phase III LFB trial studying the efficacy and safety of 10% immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), will be presented during poster sessions of the Peripheral Nerve Society (PNS) 2020 congress.
In the context of the international Covid-19 pandemic, this congress will be held virtually from 27 to 30 June. This international congress is a real place of true exchange and medical meeting. It is an annual unmissable event for healthcare professionals specialized in the pathology of the peripheral nervous system.
These posters will be presented on 27 June 2020 by Pr Eduardo Nobilé-Orazio, Professor and Head of Neurology at the University Hospital of Milan (Italy). These posters will be available on the dedicated platform “PNS virtual poster forum”, open from 16:00 (CET) on 27 June, and active until the end of July.
The abstracts, from which these posters are derived, will be published in the supplement of the Journal of the Peripheral Nerve System (JPNS).